These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 10089073)

  • 1. Quantitative analysis of the cyclin expression in human esophageal cancer cell lines.
    Fujii S; Tominaga O; Nagawa H; Tsuno N; Nita ME; Tsuruo T; Muto T
    J Exp Clin Cancer Res; 1998 Dec; 17(4):491-6. PubMed ID: 10089073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Flow cytometric detection and significance of four cyclins in esophageal cancer].
    Du Y; Wang XL; Wu GX; Wang YJ; Yang HC; Zuo LF
    Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):612-4. PubMed ID: 15634523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric quantification of cyclin E in human cell lines and hematopoietic malignancies.
    Erlanson M; Landberg G
    Cytometry; 1998 Jul; 32(3):214-22. PubMed ID: 9667511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cyclins A, D2 and D3 in individual normal mitogen stimulated lymphocytes and in MOLT-4 leukemic cells analyzed by multiparameter flow cytometry.
    Gong J; Bhatia U; Traganos F; Darzynkiewicz Z
    Leukemia; 1995 May; 9(5):893-9. PubMed ID: 7769853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-type cyclins in adult human testis and testicular cancer: relation to cell type, proliferation, differentiation, and malignancy.
    Bartkova J; Rajpert-de Meyts E; Skakkebaek NE; Bartek J
    J Pathol; 1999 Apr; 187(5):573-81. PubMed ID: 10398124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of cyclins A, B1, D3 and E in G1 phase of the cell cycle between the synchronized and asynchronously growing MOLT-4 cells.
    Yu C; Hu J; Feng Y; Tao D; Wu J; Qin J; Liu S; Zhang M; Wang G; Li X; Zhao J; Ding H; Reed E; Li QQ; Gong J
    Int J Mol Med; 2005 Oct; 16(4):645-51. PubMed ID: 16142399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cyclins and cdks throughout murine carcinogenesis.
    Yerly-Motta V; Contassot E; Pavy JJ; Tiberghien P; Hervé P
    Cell Mol Biol (Noisy-le-grand); 1999 Dec; 45(8):1217-28. PubMed ID: 10643971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Further study on cyclin D1 expression and function in human nasopharyngeal carcinoma cell line].
    Zhao X; Deng L; Weng X
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):373-5. PubMed ID: 11810764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of cell cycle regulatory proteins in benign and malignant bone and soft tissue neoplasms.
    Bui MM; Bagui TK; Boulware DC; Letson DG; Nasir A; Kaiser HE; Pledger WJ; Coppola D
    In Vivo; 2007; 21(5):729-37. PubMed ID: 18019405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia.
    Wolowiec D; Ciszak L; Kosmaczewska A; Bocko D; Teodorowska R; Frydecka I; Kuliczkowski K
    Haematologica; 2001 Dec; 86(12):1296-304. PubMed ID: 11726322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of p53, p21 (Waf1/Cip1), and cyclin D1 protein expression in esophageal cancer patients.
    Hirai T; Kuwahara M; Yoshida K; Osaki A; Toge T
    Anticancer Res; 1999; 19(5C):4587-91. PubMed ID: 10650815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expressions of cyclins A, B1, D3, and E in asynchronous and synchronous MOLT-4 cells of G1 phase].
    Yu CZ; Feng YD; Tao DD; Yu Y; Wu JH; Gong JP
    Ai Zheng; 2005 Feb; 24(2):170-4. PubMed ID: 15694027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis.
    Takano Y; Kato Y; Masuda M; Ohshima Y; Okayasu I
    J Pathol; 1999 Oct; 189(2):194-200. PubMed ID: 10547574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis.
    Park WH; Seol JG; Kim ES; Hyun JM; Jung CW; Lee CC; Kim BK; Lee YY
    Cancer Res; 2000 Jun; 60(11):3065-71. PubMed ID: 10850458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D3 expression in primary Ta/T1 bladder cancer.
    Lopez-Beltran A; Requena MJ; Luque RJ; Alvarez-Kindelan J; Quintero A; Blanca AM; Rodriguez ME; Siendones E; Montironi R
    J Pathol; 2006 May; 209(1):106-13. PubMed ID: 16482499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters.
    Lopez-Beltran A; Luque RJ; Alvarez-Kindelan J; Quintero A; Merlo F; Requena MJ; Montironi R
    Am J Clin Pathol; 2004 Sep; 122(3):444-52. PubMed ID: 15362377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D cyclins in CD5+ B-cell lymphoproliferative disorders: cyclin D1 and cyclin D2 identify diagnostic groups and cyclin D1 correlates with ZAP-70 expression in chronic lymphocytic leukemia.
    Meyerson HJ; MacLennan G; Husel W; Cocco A; Tse W; Lazarus HM; Kaplan D
    Am J Clin Pathol; 2006 Feb; 125(2):241-50. PubMed ID: 16393687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle phase abnormalities do not account for disordered proliferation in Barrett's carcinogenesis.
    Lao-Sirieix P; Brais R; Lovat L; Coleman N; Fitzgerald RC
    Neoplasia; 2004; 6(6):751-60. PubMed ID: 15720801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.